Category: Vaccines
Global Vaccines
-
Conjugate Vaccine Global Market Report 2024
... Clinics; Homecare SettingsCovering: Sanofi S.A.; Pfizer Inc.; Merck & Co. Inc.; GlaxoSmithKline plc; Bharat Biotech International Limited Conjugate Vaccine Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with ... Read More
-
Vaccine Adjuvants Global Market Report 2024
... Intranasal; Subcutaneous; Intradermal4) By Disease: Cancer; Infectious DiseasesCovering: GlaxoSmithKline Plc.; Novavax Inc.; SPI Pharma Inc.; Agenus Inc.; CSL Limited Vaccine Adjuvants Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior ... Read More
-
Exosome Research Market by Product & Service (Kits, Reagents (Antibodies, Isolation Purification), Instruments), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell) - Global Forecast to 2028
... to reach USD 356 million by 2028 from an estimated USD 169 million in 2023, at a CAGR of 16.0% during the forecast period. The growth of this market can be attributed to the increasing ... Read More
-
Animal Health Market by Pharmaceuticals (Anti Infalmmatories, Anti-Invectives, Ectoparaciticides), Vaccines (Cattle Vaccines, Companion Animal Vaccines, Equine Vaccines), Medical Feed Additives, Animal Type - Global Forecast 2024-2030
... 43.40 billion in 2023 and expected to reach USD 45.92 billion in 2024, at a CAGR 5.90% to reach USD 64.85 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Animal Vaccines Market by Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines), Animal Type (Aqua, Companion, Poultry) - Global Forecast 2024-2030
... expected to reach USD 17.75 billion in 2024, at a CAGR 8.34% to reach USD 28.72 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Animal Vaccines Market. It ... Read More
-
Global mRNA Vaccines Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... of the mRNA Vaccines industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of mRNA Vaccines. The report also introduces players in the industry ... Read More
-
Clostridium Vaccine Market by Animal Type (Bovine, Ovine, Poultry), Distribution Channel (Hospitals, Veterinary Clinics, Veterinary Research Institute) - Global Forecast 2024-2030
... expected to reach USD 573.98 million in 2024, at a CAGR 7.05% to reach USD 864.82 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Clostridium Vaccine Market. It ... Read More
-
Animal Pharmaceuticals Market by Type (Vaccine, Veterinary Drugs), Product (Anti-Inflammatories, Bronchodilators, Ectoparasiticides), Application, End User - Global Forecast 2024-2030
... reach USD 22.17 billion in 2024, at a CAGR 8.01% to reach USD 35.24 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Animal Pharmaceuticals Market. It offers a ... Read More
-
Veterinary/Animal Vaccines Market by Type (Aquaculture Vaccine, Companion Animal Vaccine, Livestock Vaccine), Disease (Aquaculture, Companion Animal, Livestock), Technology - Global Forecast 2024-2030
... and expected to reach USD 9.58 billion in 2024, at a CAGR 6.94% to reach USD 14.34 billion by 2030. Global Veterinary/Animal Vaccines Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Companion Animal Vaccine Market by Product Type (Attenuated Live Vaccine, Conjugate Vaccine, DNA Vaccine), Animal Type (Canine, Equine, Feline), Distribution Channel - Global Forecast 2024-2030
... 4.61 billion in 2023 and expected to reach USD 4.97 billion in 2024, at a CAGR 8.18% to reach USD 8.01 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Bioengineered Protein Drugs Market by Drug Type (Monoclonal Antibodies, Therapeutic Proteins, Vaccines), Disease (Arthritis, Autoimmune Disorders, Blood Disorders), End-User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 415.13 billion in 2024, at a CAGR 7.76% to reach USD 653.35 billion by 2030. Global Bioengineered Protein Drugs Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Bovine Respiratory Disease Treatment Market by Disease Type (Diphtheria, Pneumonia, Upper Respiratory Tract Infections), Treatment Type (Antibiotics, Immunomodulators, Vaccines), Distribution Channel - Global Forecast 2024-2030
... USD 1.96 billion in 2023 and expected to reach USD 2.10 billion in 2024, at a CAGR 7.58% to reach USD 3.27 billion by 2030. Global Bovine Respiratory Disease Treatment Market FPNV Positioning Matrix The ... Read More
-
Syringes Market by Type (Disposable Syringes, Prefilled Syringes, Sterilizable or Reusable Syringes), Application (Blood Specimen Collection, Drug Delivery, Vaccination), End-User - Global Forecast 2024-2030
... 2023 and expected to reach USD 10.70 billion in 2024, at a CAGR 4.76% to reach USD 14.17 billion by 2030. Global Syringes Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
2024 Global: Toxins, Cultures Of Micro-Organisms And Similar Products (Excl. Yeasts And Vaccines) Products-Manufacturing Forecast (2030) report
... analyzies the market size, projected growth/decline and regional data for the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product ... Read More
-
Celiac Disease Drugs Market by Drug (First Line of Treatment, Second Line of Treatment), Type (Steroids & Immunosuppressive Drugs, Therapeutic Vaccines, Vitamins & Dietary Supplements), Indication, End-User - Global Forecast 2024-2030
... Market size was estimated at USD 1.42 billion in 2023 and expected to reach USD 1.56 billion in 2024, at a CAGR 10.59% to reach USD 2.87 billion by 2030. FPNV Positioning Matrix The FPNV ... Read More
-
Neglected Tropical Disease Treatment Market by Product (Drugs, Vaccines), Types of Diseases (Buruli Ulcer, Chagas Disease, Dengue), Diagnostic Method - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 6.40 billion in 2024, at a CAGR 6.25% to reach USD 9.38 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Veterinary Pharmaceuticals Market by Product (Veterinary Antibiotics, Veterinary Parasiticides, Veterinary Vaccines), Vaccines (Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines), Antibiotics, End User, Animal - Global Forecast 2024-2030
... 37.59 billion in 2023 and expected to reach USD 42.91 billion in 2024, at a CAGR 14.63% to reach USD 97.79 billion by 2030. Global Veterinary Pharmaceuticals Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Aquaculture Vaccines Market by Type (DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines), Product (DNA Vaccines, Inactivated Vaccines), Route of Administration, Application, End-User - Global Forecast 2024-2030
... 354.89 million in 2023 and expected to reach USD 372.64 million in 2024, at a CAGR 4.82% to reach USD 493.67 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Microcarriers Market by Product (Consumables, Equipment), Application (Biologics Manufacturing, Cell Therapy, Vaccine Manufacturing), End User - Global Forecast 2024-2030
... USD 2.37 billion in 2024, at a CAGR 9.99% to reach USD 4.22 billion by 2030. Global Microcarriers MarketMicrocarriers are small spherical beads made from materials such as dextran, polystyrene, gelatin, or glass that provide ... Read More
-
2024 Global: Vaccines Against Sars-Related Coronaviruses "Sars-Cov Species", For Human Medicine Products-Manufacturing Forecast (2030) report
... projected growth/decline and regional data for the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and ... Read More
-
Cancer Vaccines Market by Technology (Antigen, Dendritic Cells, Recombinant Cancer Vaccines), Treatment Method (Preventive Vaccine, Therapeutic Vaccine), Application - Global Forecast 2024-2030
... and expected to reach USD 20.56 billion in 2024, at a CAGR 15.37% to reach USD 48.71 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Cancer Vaccines Market. ... Read More
-
Vaccine Adjuvants Market by Product (Adjuvant Emulsions, Combination Adjuvants, Mineral Adjuvants), Route of Administration (Intradermal, Intramuscular, Intranasal), Disease, Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 884.18 million in 2024, at a CAGR 7.88% to reach USD 1,404.20 million by 2030. Global Vaccine Adjuvants Market Vaccine adjuvants are essential components in the formulation of vaccines, ... Read More
-
Cancer Biological Therapy Market by Product (Cancer Growth Blockers, Monoclonal Antibodies, Vaccines), Route of Administration (Intramuscular, Intravenous, Subcutaneous), End-Users - Global Forecast 2024-2030
... in 2023 and expected to reach USD 72.42 billion in 2024, at a CAGR 11.60% to reach USD 140.04 billion by 2030. Global Cancer Biological Therapy Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Malaria Vaccine Market by Type (Erythrocytic Vaccine, Multi-Antigen Vaccine, Pre-Erythrocytic Vaccine), Agent (Anopheles Species, Plasmodium Falciparum, Plasmodium Vivax), End-User - Global Forecast 2024-2030
... 2023 and expected to reach USD 80.88 million in 2024, at a CAGR 25.78% to reach USD 320.66 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Malaria Vaccine ... Read More
-
Virus Filtration Market by Product (Filtration Systems, Kits & Reagents), Application (Air Purification, Biologicals, Medical Devices), End User - Global Forecast 2024-2030
... and expected to reach USD 2.49 billion in 2024, at a CAGR 14.35% to reach USD 5.60 billion by 2030. Global Virus Filtration Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
Research Assistance
